⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5495656 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL10636423 | 0.98 | TSHR (0.39) | — | |
| SCHEMBL14125402 | 0.95 | TSHR (0.50) | — | |
| SCHEMBL2638214 | 0.93 | TSHR (0.46) | — | |
| SCHEMBL5165814 | 0.88 | TSHR (0.37) | — | |
| SCHEMBL8349339 | 0.85 | TSHR (0.39) | — | |
| SCHEMBL9718442 | 0.76 | TSHR (0.50) | — | |
| SCHEMBL3661549 | 0.75 | ALDH1A1 (0.42) | — | |
| SCHEMBL934308 | 0.75 | ALDH1A1 (0.36) | — | |
| SCHEMBL16594602 | 0.75 | CA1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 503 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119930561-A | Raltitrexed initial raw material reference substance impurity as well as preparation method and application thereof | 江苏天士力帝益药业有限公司 | 2025-05-06 | — | — | CN | claimed |
| US-20230414481-A1 | Composition and Method for Producing Same and Cosmetic Agent | ASAHI KASEI FINECHEM CO., LTD. (JP) | 2023-12-28 | — | — | US | claimed |
| EP-4239037-A1 | COMPOSITION, METHOD FOR PRODUCING SAME, AND COSMETIC | Asahi Kasei Finechem Co., Ltd. (JP) | 2023-09-06 | — | — | EP | claimed |
| CN-116507696-A | Composition, method for producing same, and cosmetic | 旭化成精细化工股份有限公司 | 2023-07-28 | — | — | CN | claimed |
| CN-116196294-A | Amphiphilic polyamino acid drug-loaded nano-particle with stimulus responsiveness and preparation method thereof | 宁德师范学院 | 2023-06-02 | — | — | CN | claimed |
| CN-113801486-B | Epoxy asphalt material and preparation method thereof | 中国石油化工股份有限公司 | 2023-02-03 | — | — | CN | claimed |
| CN-112210221-B | Epoxy asphalt material and preparation method thereof | 中国石油化工股份有限公司 | 2023-01-10 | — | — | CN | claimed |
| CN-115433467-A | Cationic asphalt and preparation method thereof | 中国石油化工股份有限公司 | 2022-12-06 | — | — | CN | claimed |
| CN-115433553-A | Hydrophilic asphalt material and preparation method thereof | 中国石油化工股份有限公司 | 2022-12-06 | — | — | CN | claimed |
| CN-115433466-A | Epoxy modified asphalt and preparation method thereof | 中国石油化工股份有限公司 | 2022-12-06 | — | — | CN | claimed |
| CN-110872443-A | Environment-friendly phase-change heat-storage modified asphalt and preparation method thereof | 中国石油化工股份有限公司 | 2020-03-10 | — | — | CN | claimed |
| CN-110872442-A | Asphalt ultraviolet aging resistant modifier, modified asphalt and preparation method thereof | 中国石油化工股份有限公司 | 2020-03-10 | — | — | CN | claimed |
| CN-110872448-A | Ultraviolet aging resistant waste rubber powder modified asphalt and preparation method thereof | 中国石油化工股份有限公司 | 2020-03-10 | — | — | CN | claimed |
| US-20080026017-A1 | Novel Dipeptides incorporating selenoamino acids with enhanced bioavailability- Synthesis, pharmaceutical and cosmeceutical applications thereof | SAMI LABS LIMITED (IN) | 2008-01-31 | — | — | US | claimed |
| CN-101044188-A | Process for preparing glatiramer | SANDOZ AG (CH) | 2007-09-26 | — | — | CN | claimed |
| US-20050255160-A1 | Polymide resin dermal composition | SOHO LABORATORIES, INC. | 2005-11-17 | — | — | US | claimed |
| US-5449743-A | Enzymes as catalysts for ring opening polymerization of lactones, lactams, anhydrides or carbonates | Kobayashi, Shiro (JP) | 1995-09-12 | — | — | US | claimed |
| US-4600532-A | Process and composition for amino-terminal, α-aspartyl and α-glutamyl dipeptides and dipeptide esters | THE SALK INSTITUTE BIOTECHNOLOGY/INDUSTRIAL ASSOCIATES, INC. (US) | 1986-07-15 | — | — | US | claimed |
| EP-0052296-B1 | GLUTAMINE DERIVATIVES USABLE FOR CURING IMMUNE DISEASES, METHODS FOR THEIR PREPARATION AND COMPOSITIONS COMPRISING SAID DERIVATIVES | MITSUBISHI KASEI CORPORATION (JP) | 1984-06-27 | — | — | EP | claimed |
| EP-0052296-A1 | Glutamine derivatives usable for curing immune diseases, methods for their preparation and compositions comprising said derivatives | MITSUBISHI KASEI CORPORATION (JP) | 1982-05-26 | — | — | EP | claimed |